388 related articles for article (PubMed ID: 29737445)
1. A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibility and implication in drug discovery.
Cholko T; Chen W; Tang Z; Chang CA
J Comput Aided Mol Des; 2018 Jun; 32(6):671-685. PubMed ID: 29737445
[TBL] [Abstract][Full Text] [Related]
2. All-atomic molecular dynamic studies of human CDK8: insight into the A-loop, point mutations and binding with its partner CycC.
Xu W; Amire-Brahimi B; Xie XJ; Huang L; Ji JY
Comput Biol Chem; 2014 Aug; 51():1-11. PubMed ID: 24754906
[TBL] [Abstract][Full Text] [Related]
3. Highlighting the Major Role of Cyclin C in Cyclin-Dependent Kinase 8 Activity through Molecular Dynamics Simulations.
Ziada S; Diharce J; Serillon D; Bonnet P; Aci-Sèche S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791449
[TBL] [Abstract][Full Text] [Related]
4. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder.
Schneider EV; Böttcher J; Blaesse M; Neumann L; Huber R; Maskos K
J Mol Biol; 2011 Sep; 412(2):251-66. PubMed ID: 21806996
[TBL] [Abstract][Full Text] [Related]
5. Discovery of CDK8/CycC Ligands with a New Virtual Screening Tool.
Chen W; Ren X; Chang CA
ChemMedChem; 2019 Jan; 14(1):107-118. PubMed ID: 30403831
[TBL] [Abstract][Full Text] [Related]
6. All-Atomic Molecular Dynamic Studies of Human and
Xu W; Xie XJ; Faust AK; Liu M; Li X; Chen F; Naquin AA; Walton AC; Kishbaugh PW; Ji JY
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053834
[TBL] [Abstract][Full Text] [Related]
7. Structure-kinetic relationship study of CDK8/CycC specific compounds.
Schneider EV; Böttcher J; Huber R; Maskos K; Neumann L
Proc Natl Acad Sci U S A; 2013 May; 110(20):8081-6. PubMed ID: 23630251
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.
Park MJ; Shen H; Spaeth JM; Tolvanen JH; Failor C; Knudtson JF; McLaughlin J; Halder SK; Yang Q; Bulun SE; Al-Hendy A; Schenken RS; Aaltonen LA; Boyer TG
J Biol Chem; 2018 Mar; 293(13):4870-4882. PubMed ID: 29440396
[TBL] [Abstract][Full Text] [Related]
9. Cyclin C influences the timing of mitosis in fission yeast.
Banyai G; Szilagyi Z; Baraznenok V; Khorosjutina O; Gustafsson CM
Mol Biol Cell; 2017 Jul; 28(13):1738-1744. PubMed ID: 28515143
[TBL] [Abstract][Full Text] [Related]
10. The Mediator CDK8-Cyclin C complex modulates Dpp signaling in Drosophila by stimulating Mad-dependent transcription.
Li X; Liu M; Ren X; Loncle N; Wang Q; Hemba-Waduge RU; Yu SH; Boube M; Bourbon HG; Ni JQ; Ji JY
PLoS Genet; 2020 May; 16(5):e1008832. PubMed ID: 32463833
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2.
Wu X; Wan S; Wang G; Jin H; Li Z; Tian Y; Zhu Z; Zhang J
J Mol Graph Model; 2015 Mar; 56():103-12. PubMed ID: 25594497
[TBL] [Abstract][Full Text] [Related]
12. Binding patterns and structure-activity relationship of CDK8 inhibitors.
Ma D; Chen X; Shen XB; Sheng LQ; Liu XH
Bioorg Chem; 2020 Mar; 96():103624. PubMed ID: 32078847
[TBL] [Abstract][Full Text] [Related]
13. CDK8-Cyclin C Mediates Nutritional Regulation of Developmental Transitions through the Ecdysone Receptor in Drosophila.
Xie XJ; Hsu FN; Gao X; Xu W; Ni JQ; Xing Y; Huang L; Hsiao HC; Zheng H; Wang C; Zheng Y; Xiaoli AM; Yang F; Bondos SE; Ji JY
PLoS Biol; 2015 Jul; 13(7):e1002207. PubMed ID: 26222308
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC).
Feng D; Youn DY; Zhao X; Gao Y; Quinn WJ; Xiaoli AM; Sun Y; Birnbaum MJ; Pessin JE; Yang F
PLoS One; 2015; 10(6):e0126240. PubMed ID: 26042770
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of CDK8 and Cyclin C in tumorigenesis.
Xu W; Ji JY
J Genet Genomics; 2011 Oct; 38(10):439-52. PubMed ID: 22035865
[TBL] [Abstract][Full Text] [Related]
16. Mediator kinase module and human tumorigenesis.
Clark AD; Oldenbroek M; Boyer TG
Crit Rev Biochem Mol Biol; 2015; 50(5):393-426. PubMed ID: 26182352
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening.
Wang T; Yang Z; Zhang Y; Yan W; Wang F; He L; Zhou Y; Chen L
Eur J Med Chem; 2017 Mar; 129():275-286. PubMed ID: 28231524
[TBL] [Abstract][Full Text] [Related]
18. Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.
Callegari D; Lodola A; Pala D; Rivara S; Mor M; Rizzi A; Capelli AM
J Chem Inf Model; 2017 Feb; 57(2):159-169. PubMed ID: 28080056
[TBL] [Abstract][Full Text] [Related]
19. CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.
Xi M; Chen T; Wu C; Gao X; Wu Y; Luo X; Du K; Yu L; Cai T; Shen R; Sun H
Eur J Med Chem; 2019 Feb; 164():77-91. PubMed ID: 30594029
[TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
